Related Experiment Video
Updated: Apr 16, 2026
Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Osteoporosis and bisphosphonate-related osteonecrosis in a dental school implant patient population
Mohanad Al-Sabbagh1, Fonda G Robinson, Georgios Romanos
1*Division Chief and Graduate Program Director of Periodontology, Department of Oral Health Practice, University of Kentucky College of Dentistry, Lexington, KY. †Associate Dean, Clinic Administration and Patient Care, The Ohio State University College of Dentistry, Columbus, OH. ‡Professor, Department of Periodontology, Stony Brook University School of Dental Medicine, New York, NY. §Former Chair and Professor, Department of Oral Health Practice, University of Kentucky College of Dentistry, Lexington, KY.
Purpose:
Studies have demonstrated an inconsistent association between implant failure and bone mineral density. The prevalence of osteoporosis in US adults has been reported to range from 5% to 10% in women and from 2% to 4% in men. The prevalence of bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) has been reported to range from 0% to 4.3% of patients taking oral BPs. The purpose of this study was to calculate the risk of dental implant loss and the incidence of BRONJ in patients with osteoporosis at the University of Kentucky College of Dentistry (UKCD).
Materials And Methods:
This study analyzed data collected from patients who had implants placed between 2000 and 2004 at UKCD. Data were gathered from patient interviews regarding implant survival and patient-satisfaction parameters, and interviews were conducted either chairside at a scheduled maintenance appointment or by telephone interview.
Results:
Among 203 patients who received 515 implants, the prevalence of osteoporosis was 23.3% for women and 1.2% for men. None of the 20 patients who reported a history of oral BP use exhibited BRONJ, and there were no implant failures in patients with a history of osteoporosis.
Conclusions:
In this study, osteoporosis conferred no risk of implant failure, and oral BP therapy was not associated with BRONJ.
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Osteoclasts in Bone Remodeling
01:40Bone Remodeling
01:02What is the Skeletal System?
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:31Bone Remodeling and Repair